Thomas S. Harrison

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

John R. Perfect, William E. Dismukes, Françoise Dromer et al. · Clinical Infectious Diseases · 2010 · 2.6K citations · Full text

Cryptococcal Disease, Pathogenesis, Clinical Epidemiology +13

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

J. Peter Donnelly, Sharon Chen, Carol A. Kauffman et al. · Clinical Infectious Diseases · 2019 · 2.6K citations · Full text

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

Annemarie E. Brouwer, Adul Rajanuwong, Wirongrong Chierakul et al. · The Lancet · 2004 · 472 citations

Antifungal Agent, Antifungal Agents, Vaginitis +4

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

Amina Jindani, Thomas S. Harrison, Andrew Nunn et al. · New England Journal of Medicine · 2014 · 436 citations · Full text